Publikationen in Zusammenarbeit mit Forschern von Maastricht University Medical Centre (19)

2023

  1. Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: The EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 5, pp. 1970-1978

2022

  1. Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs

    Human Brain Mapping, Vol. 43, Núm. 1, pp. 300-328

  2. Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study

    Epidemiology and psychiatric sciences, Vol. 31, pp. e68

  3. Graph Convolutional Networks Reveal Network-Level Functional Dysconnectivity in Schizophrenia

    Schizophrenia Bulletin, Vol. 48, Núm. 4, pp. 881-892

2021

  1. Examining the association between exposome score for schizophrenia and functioning in schizophrenia, siblings, and healthy controls: Results from the EUGEI study

    European psychiatry : the journal of the Association of European Psychiatrists, Vol. 64, Núm. 1, pp. e25

  2. Primary prevention of depression: An umbrella review of controlled interventions

    Journal of Affective Disorders, Vol. 294, pp. 957-970

  3. The Independent Effects of Psychosocial Stressors on Subclinical Psychosis: Findings from the Multinational EU-GEI Study

    Schizophrenia Bulletin, Vol. 47, Núm. 6, pp. 1674-1684

  4. The search for an autoimmune origin of psychotic disorders: Prevalence of autoantibodies against hippocampus antigens, glutamic acid decarboxylase and nuclear antigens

    Schizophrenia Research, Vol. 228, pp. 462-471

2020

  1. De novo mutations identified by exome sequencing implicate rare missense variants in SLC6A1 in schizophrenia

    Nature Neuroscience, Vol. 23, Núm. 2, pp. 179-184

  2. Detecting schizophrenia at the level of the individual: Relative diagnostic value of whole-brain images, connectome-wide functional connectivity and graph-based metrics

    Psychological Medicine, Vol. 50, Núm. 11, pp. 1852-1861

  3. Integrating machining learning and multimodal neuroimaging to detect schizophrenia at the level of the individual

    Human Brain Mapping, Vol. 41, Núm. 5, pp. 1119-1135

  4. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention

    JAMA Psychiatry, Vol. 77, Núm. 7, pp. 755-765

  5. Replicated evidence that endophenotypic expression of schizophrenia polygenic risk is greater in healthy siblings of patients compared to controls, suggesting gene-environment interaction. The EUGEI study

    Psychological Medicine, Vol. 50, Núm. 11, pp. 1884-1897

2019

  1. Estimating Exposome Score for Schizophrenia Using Predictive Modeling Approach in Two Independent Samples: The Results From the EUGEI Study

    Schizophrenia bulletin, Vol. 45, Núm. 5, pp. 960-965

  2. European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)

    European Neuropsychopharmacology, Vol. 29, Núm. 12, pp. 1301-1311

  3. Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study

    World Psychiatry, Vol. 18, Núm. 2, pp. 173-182

  4. White noise speech illusions: A trait-dependent risk marker for psychotic disorder?

    Frontiers in Psychiatry, Vol. 10, Núm. SEP

2016

  1. Diagnostic procedures for non-small-cell lung cancer (NSCLC): Recommendations of the European Expert Group

    Thorax, Vol. 71, Núm. 2, pp. 177-184

2011

  1. Diagnostic criteria for apathy in clinical practice

    International Journal of Geriatric Psychiatry, Vol. 26, Núm. 2, pp. 158-165